Letters Twin dilemma

Belgium model of coupling reimbursement of ART costs to restriction in number of embryos transferred

BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1559 (Published 19 February 2014) Cite this as: BMJ 2014;348:g1559
  1. Diane De Neubourg, head of clinic1,
  2. Karen Peeraer, associate head of clinic1,
  3. Sophie Debrock, senior clinical embryologist1,
  4. Thomas D’Hooghe, coordinator, Leuven University Fertility Centre1
  1. 1Leuven University Fertility Centre, Department of Obstetrics and Gynaecology, University Hospitals of Leuven, 3000 Leuven, Belgium
  1. diane.deneubourg{at}uzleuven.be

Multiple pregnancy rates after treatment with assisted reproductive technology (ART) remain high (20.2% in Europe; 26.9% worldwide) and are associated with major societal costs (usually reimbursed and paid for by public health funds).1 2 They represent the most important side effect of ART treatment (usually not reimbursed and provided in private practice). In view of the Human …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe